Forecast to Publish a Funding Opportunity Announcement for the Cancer Intervention and Surveillance Modeling Network (CISNET) (U01 Clinical Trial Not Allowed)
ID: 359729Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Cancer Intervention and Surveillance Modeling Network (CISNET) under the U01 cooperative agreement mechanism, which will not allow clinical trials. This initiative aims to leverage simulation modeling to enhance the evidence derived from clinical trials, epidemiologic studies, and surveillance data, thereby informing public health research and priorities throughout the cancer continuum. The opportunity is particularly relevant for small businesses with expertise in comparative simulation modeling methods for cancer control, as well as collaborative teams that integrate knowledge from decision modeling, statistics, health economics, epidemiology, computer science, medicine, and public health. Interested applicants should prepare for the application process, with the estimated synopsis posting date set for July 31, 2025, and the application deadline anticipated for November 7, 2025. For further inquiries, potential applicants can contact Dr. Natasha Stout at natasha.stout@nih.gov or by phone at 240-478-8909.

    Point(s) of Contact
    Natasha Stout, Ph.D. National Cancer Institute (NCI)
    (240) 478-8909
    natasha.stout@nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    Cancer Intervention and Surveillance Modeling Network (CISNET) (U01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Cancer Intervention and Surveillance Modeling Network (CISNET) through a Notice of Funding Opportunity (NOFO) aimed at collaborative research projects utilizing simulation and modeling techniques for specific cancer types. The primary objective is to develop evidence-based tools that inform efficient strategies for cancer control, focusing on comparative modeling for cancers such as bladder, breast, cervix, colon/rectum, esophagus, gastric, multiple myeloma, lung, prostate, and uterine. This initiative is crucial for enhancing cancer control efforts and improving outcomes in at-risk populations. The NIH plans to allocate approximately $9.438 million in FY 2026 to fund up to eight awards, with applications due by February 11, 2026. Interested applicants can reach out to Natasha Stout at natasha.stout@nih.gov for further information.
    Forecast to Publish a Notice of Funding Opportunity (NOFO) for NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to publish a Notice of Funding Opportunity (NOFO) for the National Cancer Institute (NCI) Community Oncology Research Program (NCORP) Research Bases, which requires clinical trials. This initiative aims to enhance the generalizability and dissemination of clinical trial results by engaging diverse cancer patient populations and organizations in rigorous studies focused on cancer control, prevention, treatment, and care delivery. The program anticipates awarding approximately $73 million across 50 grants, with applications from small businesses eligible, provided they are not affiliated with certain NCI-funded institutions. Interested applicants can reach out to Dr. Brandy Heckman-Stoddard at 240-276-7048 or via email at heckmanbm@mail.nih.gov for further information. The estimated synopsis will be posted on August 29, 2025, with a closing date for applications on November 14, 2025, and awards expected to be made by August 1, 2026.
    Forecast to Publish a Notice of Funding Opportunity (NOFO) for NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to publish a Notice of Funding Opportunity (NOFO) for the NCI Community Oncology Research Program (NCORP) Research Bases, which requires clinical trials. This initiative aims to enhance the generalizability and dissemination of clinical trial results by engaging cancer patient populations and organizations in rigorous studies focused on cancer control, prevention, treatment, and care delivery. The program will support seven awards with an estimated total funding of $60 million, and applications are open to small businesses. Interested applicants should note that the synopsis is expected to be posted on August 29, 2025, with a closing date for applications on November 14, 2025, and the anticipated award date is August 1, 2026. For further inquiries, contact Brandy Heckman-Stoddard, Ph.D., M.P.H., at 240-276-7048 or via email at heckmanbm@mail.nih.gov.
    Notice of Intent to Publish a Funding Opportunity Announcement for NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers (UG1 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a funding opportunity for the NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers, designated as a UG1 Clinical Trial Not Allowed cooperative agreement. This initiative aims to support leadership and expertise in integrating translational science into clinical trials, particularly focusing on multi-center, late-phase treatment trials across various cancer types and patient demographics. The total estimated program funding is $2 million, with an award ceiling of $850,000 and an expected two awards to be made. The Notice of Funding Opportunity (NOFO) is anticipated to be published in Fall 2024, with applications due in late February 2025, and awards expected to be announced by March 1, 2026. Interested applicants should prepare their proposals accordingly.
    Forecast to Publish a Funding Opportunity Announcement for Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity for the establishment of cancer epidemiology cohorts through the "Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts" initiative. This cooperative agreement aims to address critical knowledge gaps in cancer etiology and survivorship by laying the groundwork for future studies that will explore various factors influencing cancer risk and outcomes. Eligible applicants for this discretionary grant include small businesses, with no cost-sharing or matching requirements. Interested parties should note that the estimated synopsis post date is August 1, 2025, and applications are due by November 5, 2025, with awards expected to be made by July 1, 2026. For further inquiries, contact Naoko Ishibe Simonds, Sc.D., or Lisa Gallicchio, Ph.D., at 240-276-6967 or via email at naoko.simonds@nih.gov.
    Forecast to Publish a Notice of Funding Opportunity for The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Metastasis Research Network (MetNet), specifically targeting research projects under the U01 Clinical Trial Not Allowed funding mechanism. This initiative aims to solicit applications that utilize integrative systems-level approaches to address critical questions in metastasis research, aligning with the ongoing efforts of the MetNet, which focuses on understanding the complex dynamics of metastasis through collaborative research. The anticipated NOFO is expected to be published in Summer 2025, with applications due in Fall 2025, and will support approximately 10 awards, with no cost-sharing or matching requirements. For further inquiries, interested applicants can contact Joanna M. Watson, Ph.D., at watsonjo@mail.nih.gov or by phone at 240-276-6206.
    Forecast to Publish a Funding Opportunity Announcement for Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity for research in cancer epidemiology cohort studies through a Cooperative Agreement. This initiative aims to support hypothesis-based research that addresses critical knowledge gaps in cancer etiology and survivorship, including the maintenance of cohorts, continued follow-up, and the sharing of data and biospecimen resources. This funding is vital for advancing understanding in the field of cancer research, which can lead to improved outcomes for patients. Interested small businesses can reach out to Dr. Somdat Mahabir at mahabir@mail.nih.gov or call 240-276-6914 for more information. The estimated synopsis post date is August 1, 2025, with applications due by November 5, 2025, and awards expected to be made by July 1, 2026.
    Forecast to Publish a Funding Opportunity Announcement for Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at soliciting applications for the early-stage development of informatics technologies that enhance cancer research and management. This initiative, part of the National Cancer Institute's Informatics Technology for Cancer Research (ITCR) Program, seeks to support the creation and significant modification of tools that facilitate data acquisition, management, analysis, and dissemination across various cancer research domains, including biology, treatment, early detection, and health disparities. Interested small businesses are encouraged to develop innovative, user-friendly technologies that demonstrate potential impact on cancer research, with applications expected to be submitted after the NOFO is officially released. For further inquiries, potential applicants can contact Dr. Juli Klemm at juli.klemm@nih.gov or by phone at 202-853-7889, with the estimated synopsis post date set for August 29, 2025, and the anticipated award date in July 2026.
    Forecast to Publish a Funding Opportunity Announcement for Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at supporting the sustained development of informatics technologies for cancer research and management. This initiative seeks applications for the continued operation and enhancement of existing informatics resources that facilitate data acquisition, management, analysis, and dissemination across various aspects of cancer research, including biology, treatment, early detection, and health disparities. The emphasis is on maintaining resources that have demonstrated significant impact on cancer research, with a focus on user engagement and support. While applications are not currently being solicited, potential applicants are encouraged to prepare collaborative projects in anticipation of the NOFO, which is expected to be posted on August 29, 2025, with a closing date for submissions on November 21, 2025. For further inquiries, interested parties can contact Dr. Juli Klemm at juli.klemm@gmail.com or by phone at 202-853-7889.
    Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition: NCI National Clinical Trials Network - Network Group Operations Centers (U10 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a funding opportunity announcement for the NCI National Clinical Trials Network (NCTN) - Network Group Operations Centers, which will require a U10 clinical trial. This initiative aims to provide scientific leadership for the development and implementation of multi-disciplinary, multi-institutional clinical trials targeting various cancer types and populations, focusing on late-phase treatment trials and advanced imaging studies. The funding, estimated at $99.3 million, is intended to support the conduct of essential clinical research for adults, adolescents, and children with cancer, with the NOFO expected to be published in Fall 2024 and applications due by late February 2025. For further details, applicants should prepare their submissions in advance of the anticipated award date of March 1, 2026.